Guided Therapeutics, Inc. (GTHP)
USD 0.08
(-0.12%)
USD 0.08
(-0.12%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -3.45 Million USD | -3.72% |
| 2022 | -3.33 Million USD | -41.11% |
| 2021 | -2.36 Million USD | -124.52% |
| 2020 | -1.05 Million USD | -12.27% |
| 2019 | -937 Thousand USD | 39.47% |
| 2018 | -1.54 Million USD | 50.4% |
| 2017 | -3.12 Million USD | 18.3% |
| 2016 | -3.82 Million USD | 38.65% |
| 2015 | -6.22 Million USD | 28.17% |
| 2014 | -8.66 Million USD | -31.23% |
| 2013 | -6.6 Million USD | -54.31% |
| 2012 | -4.28 Million USD | 36.63% |
| 2011 | -6.75 Million USD | -316.78% |
| 2010 | -1.62 Million USD | 12.85% |
| 2009 | -1.86 Million USD | 39.35% |
| 2008 | -3.06 Million USD | -227.05% |
| 2007 | 2.41 Million USD | 154.38% |
| 2006 | -4.43 Million USD | -134.5% |
| 2005 | -1.89 Million USD | 79.88% |
| 2004 | -9.4 Million USD | -45.45% |
| 2003 | -6.46 Million USD | 20.01% |
| 2002 | -8.08 Million USD | -11.78% |
| 2001 | -7.23 Million USD | -7.95% |
| 2000 | -6.7 Million USD | -0.03% |
| 1999 | -6.7 Million USD | 10.67% |
| 1998 | -7.5 Million USD | -27.12% |
| 1997 | -5.9 Million USD | -96.67% |
| 1996 | -3 Million USD | -279.75% |
| 1995 | -790 Thousand USD | 35.25% |
| 1994 | -1.22 Million USD | 1.61% |
| 1993 | -1.24 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -655 Thousand USD | -82.45% |
| 2024 Q1 | -359 Thousand USD | 25.98% |
| 2023 Q3 | -623 Thousand USD | 58.6% |
| 2023 FY | -3.45 Million USD | -3.72% |
| 2023 Q1 | -843 Thousand USD | 11.08% |
| 2023 Q4 | -485 Thousand USD | 22.15% |
| 2023 Q2 | -1.5 Million USD | -78.53% |
| 2022 FY | -3.33 Million USD | -41.11% |
| 2022 Q3 | -1.22 Million USD | -70.71% |
| 2022 Q2 | -717 Thousand USD | -61.85% |
| 2022 Q1 | -443 Thousand USD | -1.84% |
| 2022 Q4 | -948 Thousand USD | 22.55% |
| 2021 Q3 | -487 Thousand USD | 13.19% |
| 2021 Q1 | -823 Thousand USD | -185.76% |
| 2021 Q2 | -561 Thousand USD | 31.83% |
| 2021 Q4 | -435 Thousand USD | 10.68% |
| 2021 FY | -2.36 Million USD | -124.52% |
| 2020 Q1 | -242 Thousand USD | -46.67% |
| 2020 Q4 | -288 Thousand USD | -88.24% |
| 2020 Q2 | -369 Thousand USD | -52.48% |
| 2020 Q3 | -153 Thousand USD | 58.54% |
| 2020 FY | -1.05 Million USD | -12.27% |
| 2019 Q1 | -257 Thousand USD | 42.76% |
| 2019 Q3 | -188 Thousand USD | 42.51% |
| 2019 Q4 | -165 Thousand USD | 12.23% |
| 2019 Q2 | -327 Thousand USD | -27.24% |
| 2019 FY | -937 Thousand USD | 39.47% |
| 2018 Q1 | -376 Thousand USD | 48.56% |
| 2018 Q4 | -449 Thousand USD | -91.88% |
| 2018 FY | -1.54 Million USD | 50.4% |
| 2018 Q2 | -491 Thousand USD | -30.59% |
| 2018 Q3 | -234 Thousand USD | 52.34% |
| 2017 Q4 | -731 Thousand USD | 45.41% |
| 2017 FY | -3.12 Million USD | 18.3% |
| 2017 Q1 | -514 Thousand USD | 53.86% |
| 2017 Q2 | -533 Thousand USD | -3.7% |
| 2017 Q3 | -1.33 Million USD | -151.22% |
| 2016 FY | -3.82 Million USD | 38.65% |
| 2016 Q1 | -1.13 Million USD | 26.81% |
| 2016 Q3 | -679 Thousand USD | 24.39% |
| 2016 Q4 | -1.11 Million USD | -64.06% |
| 2016 Q2 | -898 Thousand USD | 20.53% |
| 2015 Q1 | -1.47 Million USD | 31.46% |
| 2015 FY | -6.22 Million USD | 28.17% |
| 2015 Q2 | -1.61 Million USD | -9.37% |
| 2015 Q3 | -1.83 Million USD | -14.09% |
| 2015 Q4 | -1.54 Million USD | 16.0% |
| 2014 FY | -8.66 Million USD | -31.23% |
| 2014 Q2 | -2.02 Million USD | 2.5% |
| 2014 Q1 | -2.07 Million USD | -54.0% |
| 2014 Q3 | -2.41 Million USD | -19.14% |
| 2014 Q4 | -2.14 Million USD | 11.01% |
| 2013 FY | -6.6 Million USD | -54.31% |
| 2013 Q4 | -1.35 Million USD | 17.68% |
| 2013 Q3 | -1.64 Million USD | 5.8% |
| 2013 Q2 | -1.74 Million USD | 7.15% |
| 2013 Q1 | -1.87 Million USD | -60.67% |
| 2012 Q1 | -996 Thousand USD | 65.44% |
| 2012 Q4 | -1.16 Million USD | -20.31% |
| 2012 Q3 | -970 Thousand USD | 15.51% |
| 2012 Q2 | -1.14 Million USD | -15.26% |
| 2012 FY | -4.28 Million USD | 36.63% |
| 2011 Q4 | -2.88 Million USD | -8.8% |
| 2011 Q2 | -485 Thousand USD | 34.46% |
| 2011 FY | -6.75 Million USD | -316.78% |
| 2011 Q3 | -2.64 Million USD | -446.19% |
| 2011 Q1 | -740 Thousand USD | -90.72% |
| 2010 Q3 | -605 Thousand USD | -13.94% |
| 2010 Q1 | -190 Thousand USD | 62.89% |
| 2010 FY | -1.62 Million USD | 12.85% |
| 2010 Q2 | -531 Thousand USD | -179.47% |
| 2010 Q4 | -388 Thousand USD | 35.87% |
| 2009 Q4 | -512 Thousand USD | -129.6% |
| 2009 FY | -1.86 Million USD | 39.35% |
| 2009 Q2 | -522 Thousand USD | 13.29% |
| 2009 Q3 | -223 Thousand USD | 57.28% |
| 2009 Q1 | -602 Thousand USD | 8.93% |
| 2008 Q2 | -737 Thousand USD | -24.49% |
| 2008 Q1 | -592 Thousand USD | 31.24% |
| 2008 FY | -3.06 Million USD | -227.05% |
| 2008 Q4 | -661 Thousand USD | 38.68% |
| 2008 Q3 | -1.07 Million USD | -46.27% |
| 2007 FY | 2.41 Million USD | 154.38% |
| 2007 Q4 | -861 Thousand USD | 4.97% |
| 2007 Q3 | -906 Thousand USD | -119.28% |
| 2007 Q2 | 4.7 Million USD | 725.83% |
| 2007 Q1 | -751 Thousand USD | 25.27% |
| 2006 Q3 | -1.01 Million USD | 25.42% |
| 2006 Q4 | -1 Million USD | 1.28% |
| 2006 Q2 | -1.36 Million USD | -29.88% |
| 2006 FY | -4.43 Million USD | -134.5% |
| 2006 Q1 | -1.05 Million USD | -167.72% |
| 2005 FY | -1.89 Million USD | 79.88% |
| 2005 Q1 | -1.2 Million USD | 72.63% |
| 2005 Q2 | -1.2 Million USD | -0.17% |
| 2005 Q3 | -1.05 Million USD | 12.47% |
| 2005 Q4 | 1.55 Million USD | 247.39% |
| 2004 FY | -9.4 Million USD | -45.45% |
| 2004 Q1 | -1.58 Million USD | -13.84% |
| 2004 Q2 | -1.73 Million USD | -9.26% |
| 2004 Q3 | -1.69 Million USD | 2.13% |
| 2004 Q4 | -4.38 Million USD | -158.42% |
| 2003 Q1 | -1.2 Million USD | 14.73% |
| 2003 FY | -6.46 Million USD | 20.01% |
| 2003 Q4 | -1.39 Million USD | 24.35% |
| 2003 Q3 | -1.84 Million USD | 8.98% |
| 2003 Q2 | -2.02 Million USD | -68.27% |
| 2002 Q3 | -1.07 Million USD | 66.43% |
| 2002 FY | -8.08 Million USD | -11.78% |
| 2002 Q2 | -3.19 Million USD | -32.83% |
| 2002 Q1 | -2.4 Million USD | -29.77% |
| 2002 Q4 | -1.41 Million USD | -31.59% |
| 2001 FY | -7.23 Million USD | -7.95% |
| 2001 Q3 | -1.63 Million USD | -16.48% |
| 2001 Q2 | -1.4 Million USD | 40.24% |
| 2001 Q1 | -2.34 Million USD | -1055.67% |
| 2001 Q4 | -1.85 Million USD | -13.53% |
| 2000 Q1 | -1.76 Million USD | -46.75% |
| 2000 FY | -6.7 Million USD | -0.03% |
| 2000 Q4 | -203 Thousand USD | 91.82% |
| 2000 Q3 | -2.48 Million USD | -10.11% |
| 2000 Q2 | -2.25 Million USD | -28.05% |
| 1999 Q1 | -1.9 Million USD | -11.76% |
| 1999 Q3 | -1.1 Million USD | 56.0% |
| 1999 FY | -6.7 Million USD | 10.67% |
| 1999 Q4 | -1.2 Million USD | -9.09% |
| 1999 Q2 | -2.5 Million USD | -31.58% |
| 1998 FY | -7.5 Million USD | -27.12% |
| 1998 Q4 | -1.7 Million USD | 10.53% |
| 1998 Q3 | -1.9 Million USD | 17.39% |
| 1998 Q2 | -2.3 Million USD | -9.52% |
| 1998 Q1 | -2.1 Million USD | -10.53% |
| 1997 Q1 | -1.2 Million USD | -36.36% |
| 1997 FY | -5.9 Million USD | -96.67% |
| 1997 Q2 | -1.3 Million USD | -8.33% |
| 1997 Q3 | -1.4 Million USD | -7.69% |
| 1997 Q4 | -1.9 Million USD | -35.71% |
| 1996 FY | -3 Million USD | -279.75% |
| 1996 Q4 | -880 Thousand USD | -3.53% |
| 1996 Q3 | -850 Thousand USD | -14.86% |
| 1996 Q2 | -740 Thousand USD | -13.85% |
| 1996 Q1 | -650 Thousand USD | 0.0% |
| 1995 FY | -790 Thousand USD | 35.25% |
| 1994 FY | -1.22 Million USD | 1.61% |
| 1993 FY | -1.24 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -1160.345% |
| IR-Med Inc. | -4.91 Million USD | 29.607% |
| Polarean Imaging plc | -12.55 Million USD | 72.468% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 888.945% |
| Avitar, Inc. | 2.73 Million USD | 226.5% |
| AVITA Medical, Inc. | -40.4 Million USD | 91.444% |
| Manhattan Scientifics, Inc. | -703 Thousand USD | -391.75% |
| Össur hf. | 87.46 Million USD | 103.953% |
| Zecotek Photonics Inc. | -3.65 Million USD | 5.463% |
| QHSLab, Inc. | -240.15 Thousand USD | -1339.469% |
| Wellstar International, Inc. | -1.79 Million USD | -92.623% |
| Össur hf. | 87.46 Million USD | 103.953% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 266.122% |
| Escalon Medical Corp. | -104.47 Thousand USD | -3208.894% |
| Aurora Spine Corporation | -446.19 Thousand USD | -674.772% |
| BrainsWay Ltd. | -4.92 Million USD | 29.836% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.45 Million USD | 63.454% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 1343.539% |
| Vivos Inc. | -2.79 Million USD | -23.767% |
| MicroPort Scientific Corporation | -516.16 Million USD | 99.33% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | -1345.44% |
| REMSleep Holdings, Inc. | -1.77 Million USD | -95.13% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -812.363% |
| Nanomix Corporation | -8.43 Million USD | 59.027% |
| Theraclion SA | -3.48 Million USD | 0.687% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | -388.948% |
| Positron Corporation | -1.36 Million USD | -154.051% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.06 Million USD | -67.414% |
| Lombard Medical, Inc. | -29.33 Million USD | 88.215% |
| ALR Technologies Inc. | -2.94 Million USD | -17.333% |
| Stratec SE | 25.26 Million USD | 113.681% |
| Vycor Medical, Inc. | 40.19 Thousand USD | 8701.428% |
| Heart Tronics, Inc. | 14.46 Million USD | 123.907% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | -2768.261% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 83.323% |
| SANUWAVE Health, Inc. | -540 Thousand USD | -540.185% |
| VMS Rehab Systems, Inc. | -68.66 USD | -5034854.85% |
| Ingen Technologies, Inc. | -1.61 Million USD | -114.236% |
| Odyssey Group International, Inc. | 14.26 Million USD | 124.241% |
| United American Healthcare Corporation | -67 Thousand USD | -5059.701% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | -748.385% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | -444.677% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | -474.71% |
| Urologix, Inc. | -6.93 Million USD | 50.115% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | -173.641% |
| Nexeon MedSystems Inc. | -6.26 Million USD | 44.82% |
| SS Innovations International, Inc. | -20.66 Million USD | 83.274% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | -1401.47% |
| Smith & Nephew plc | 425 Million USD | 100.813% |
| NIOX Group Plc | 4.6 Million USD | 175.152% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 1000.683% |
| Broncus Holding Corporation | -33.22 Million USD | 89.594% |
| Brain Scientific Inc. | -9.6 Million USD | 64.021% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 63.623% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | -5595.316% |